Quality of life of patients with cardiomyopathy treated with sacubitril/valsartan vs. standard therapy during or after COVID-19 in Kazakhstan

• Autores principales: Dana Dadanbekova (Autor), Kairat Zhakipbekov (Autor), Almat Kodasbayev (Autor), Ubaidilla Datkhayev (Autor), Guenka Petrova (Autor), Konstantin Tachkov (Autor)
• Formato: Libro
• Publicado: Pensoft Publishers, 2024-06-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

The objective of this study is to evaluate the quality of life (QoL) of hospitalised patients with cardiomyopathy (CM) treated with a fixed dose combination (FDC) of sacubitril/valsartan, or standard therapy in Kazakhstan during or after COVID-19. This is an observational study of patients with inci...